KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)R&D In ProcessShares OutstandingShort-Term Debt issuances
Ratios

Bristol Myers Squibb (BMY) Long-Term Debt Issuances (2016 - 2024)

Historic Long-Term Debt Issuances for Bristol Myers Squibb (BMY) over the last 9 years, with Q1 2024 value amounting to $12.9 billion.

  • Bristol Myers Squibb's Long-Term Debt Issuances changed N/A to $12.9 billion in Q1 2024 from the same period last year, while for Dec 2024 it was $12.9 billion, marking a year-over-year increase of 18918.07%. This contributed to the annual value of $12.9 billion for FY2024, which is 18918.07% up from last year.
  • As of Q1 2024, Bristol Myers Squibb's Long-Term Debt Issuances stood at $12.9 billion.
  • Over the past 5 years, Bristol Myers Squibb's Long-Term Debt Issuances peaked at $12.9 billion during Q1 2024, and registered a low of $4.5 billion during Q4 2023.
  • Moreover, its 4-year median value for Long-Term Debt Issuances was $6.4 billion (2020), whereas its average is $7.6 billion.
  • Examining YoY changes over the last 5 years, Bristol Myers Squibb's Long-Term Debt Issuances showed a top increase of 1305.71% in 2020 and a maximum decrease of 1305.71% in 2020.
  • Quarter analysis of 4 years shows Bristol Myers Squibb's Long-Term Debt Issuances stood at $6.9 billion in 2020, then dropped by 14.67% to $5.9 billion in 2022, then fell by 24.82% to $4.5 billion in 2023, then surged by 189.18% to $12.9 billion in 2024.
  • Its Long-Term Debt Issuances stands at $12.9 billion for Q1 2024, versus $4.5 billion for Q4 2023 and $5.9 billion for Q1 2022.